Ordin nr. 1301/500/2008 din 11 iulie 2008 Partea a ii-a
Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului
Yüklə 4,39 Mb.
|
| Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
________________________________________________________________________________ DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J01CR02 AMOXICILLINUM + PULB. PT. SOL. 1.2 g ACIDUM CLAVULANICUM INJ./PERF. AMOXIPLUS 1.2g 1.2 g ANTIBIOTICE SA J01CR02 AMOXICILLINUM + COMPR. FILM. 1000 mg ACIDUM CLAVULANICUM MEDOCLAV 1000 mg 1000 mg MEDOCHEMIE LTD.
ACIDUM CLAVULANICUM INJ./PERF. AUGMENTIN INTRAVENOS 1.2 g 1000 mg + 200 mg BEECHAM GROUP PLC
ACIDUM CLAVULANICUM PREL. AUGMENTIN(TM) SR 1062.5 mg BEECHAM GROUP PLC
ACIDUM CLAVULANICUM MEDOCLAV 156.25 mg/5 ml 125 mg + 31.25/5 ml MEDOCHEMIE LTD.
ACIDUM CLAVULANICUM AMOKSIKLAV 156.25 mg/5 ml 156.25 mg/5 ml LEK PHARMACEUTICALS D.D. BIOCLAVID 156.25 mg/5 ml 156.25 mg/5 ml SANDOZ GMBH J01CR02 AMOXICILLINUM + PULB. PT. SOL. PERF. 2000 mg + 200 mg ACIDUM CLAVULANICUM AUGMENTIN INTRAVENOS 2.2 g 2000 mg + 200 mg BEECHAM GROUP PLC
ACIDUM CLAVULANICUM FORCID SOLUTAB 250/62,5 250/62,5 mg ASTELLAS PHARMA EUROPE BV
ACIDUM CLAVULANICUM MEDOCLAV 375 mg 250 mg + 125 mg MEDOCHEMIE LTD.
ACIDUM CLAVULANICUM 5 ml MEDOCLAV FORTE 312,5 mg/5 ml 250 mg + 62.5 mg/5 ml MEDOCHEMIE LTD.
ACIDUM CLAVULANICUM BIOCLAVID 312.5 mg/5 ml 312.5 mg/5 ml SANDOZ GMBH
ACIDUM CLAVULANICUM AMOKSIKLAV 312.5 mg/5 ml 312.5 mg/5 ml LEK PHARMACEUTICALS D.D. ENHANCIN 312.5 mg/5 ml 312.5 mg/5 ml RANBAXY UK LIMITED J01CR02 AMOXICILLINUM + PULB. PT. SUSP. ORALA 400 mg + 57 mg/5 ml ACIDUM CLAVULANICUM AUGMENTIN BIS 400 mg + 57 mg/5 ml SMITHKLINE BEECHAM PLC
ACIDUM CLAVULANICUM FORCID SOLUTAB 500/125 500/125 mg ASTELLAS PHARMA EUROPE BV
ACIDUM CLAVULANICUM AUGMENTIN 625 mg 500 mg + 125 mg BEECHAM GROUP PLC MEDOCLAV 625 mg 500 mg + 125 mg MEDOCHEMIE LTD. J01CR02 AMOXICILLINUM + PULB. PT. SOL. INJ./ 600 mg ACIDUM CLAVULANICUM PERF. AMOXIPLUS 600 mg 600 mg ANTIBIOTICE SA
ACIDUM CLAVULANICUM AMOKSIKLAV 2 x 625 mg 625 mg LEK PHARMACEUTICALS D.D. BIOCLAVID 625 mg 625 mg SANDOZ GMBH ENHANCIN 625 mg 625 mg RANBAXY UK LIMITED
ACIDUM CLAVULANICUM AUGMENTIN(R) ES 642.90 mg/5 ml SMITHKLINE BEECHAM PLC
ACIDUM CLAVULANICUM FORCID SOLUTAB 875/125 875 mg + 125 mg ASTELLAS PHARMA EUROPE BV
ACIDUM CLAVULANICUM AUGMENTIN 1g 875 mg + 125 mg BEECHAM GROUP PLC ________________________________________________________________________________ ______________________________________________________________________________ | 630 |J01CR05| PIPERACILLINUM + TAZOBACTAMUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J01CR05 PIPERACILLINUM + LIOF. PT. SOL. INJ. TAZOBACTAMUM TAZOCIN 2,25 WYETH LEDERLE PHARMA GMBH TAZOCIN 4,5 WYETH LEDERLE PHARMA GMBH ________________________________________________________________________________ ______________________________________________________________________________ | 631 |J01CR50| COMBINATII (CEFOPERAZONUM + SULBACTAM) | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J01CR50 COMBINATII PULB. PT. SOL. INJ. 1 g + 1 g (CEFOPERAZONUM + SULBACTAM) SULPERAZON(R) 2 g 1 g + 1 g PFIZER EUROPE MA EEIG ________________________________________________________________________________ ______________________________________________________________________________ | 632 |J01DD04| CEFTRIAXONUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J01DD04 CEFTRIAXONUM PULB. PT. SOL. INJ. 0.5 g NOVOSEF 0.5 g i.v. 0.5 g ECZACIBASI PHARMACEUTICALS S.R.L.
LENDACIN 1 g 1 g LEK PHARMACEUTICALS D.D. NOVOSEF 1 g i.m. 1 g ECZACIBASI PHARMACEUTICALS S.R.L. NOVOSEF 1 g i.v. 1 g ECZACIBASI PHARMACEUTICALS S.R.L. J01DD04 CEFTRIAXONUM PULB. PT. SOL. INJ./ 1 g PERF.
CEFORT 1 g 1 g ANTIBIOTICE SA CEFTRIAXON 1 g 1 g OZONE LABORATORIES LTD. J01DD04 CEFTRIAXONUM PULB. PT. SOL. INJ. 250 mg LENDACIN 250 mg 250 mg LEK PHARMACEUTICALS D.D. J01DD04 CEFTRIAXONUM PULB. PT. SOL. INJ./ 250 mg PERF.
CEFORT 250 mg 250 mg ANTIBIOTICE SA J01DD04 CEFTRIAXONUM PULB. PT. SOL. INJ./ 2 g PERF.
CEFORT 2 g 2 g ANTIBIOTICE SA MEDAXONE 2 g 2 g MEDOCHEMIE LTD. J01DD04 CEFTRIAXONUM PULB. PT. SOL. PERF. 2 g ROCEPHIN(R) 2 g ROCHE ROMANIA S.R.L. J01DD04 CEFTRIAXONUM PULB. PT. SOL. INJ./ 500 mg PERF.
CEFORT 500 mg 500 mg ANTIBIOTICE SA J01DD04 CEFTRIAXONUM PULB. PT. SOL. INJ. 0.5 g NOVOSEF 0.5 g i.v. 0.5 g ECZACIBASI PHARMACEUTICALS S.R.L.
PERF.
CEFORT 500 mg 500 mg ANTIBIOTICE SA J01DD04 CEFTRIAXONUM PULB. + SOLV. PT. SOL. 0.5 g INJ./PERF. NOVOSEF 0.5 g i.m. 0.5 g ECZACIBASI PHARMACEUTICALS S.R.L.
________________________________________________________________________________ ______________________________________________________________________________ | 633 |J01DD08| CEFIXIMUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J01DD08 CEFIXIMUM GRAN. PT. SUSP. ORALA 100 mg/5 ml SUPRAX 100 mg/5 ml GEDEON RICHTER LTD.
EFICEF(R) 200 mg 200 mg ANTIBIOTICE SA J01DD08 CEFIXIMUM COMPR. FILM. 200 mg SUPRAX 200 mg GEDEON RICHTER LTD. ________________________________________________________________________________
| 634 |J01DD12| CEFOPERAZONUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J01DD12 CEFOPERAZONUM PULB. PT. SOL. INJ. 1 g LYZONE 1 g 1 g MEDICAROM GROUP S.R.L. MEDOCEF 1 g 1 g MEDOCHEMIE LTD. J01DD12 CEFOPERAZONUM PULB. PT. SOL. INJ. 2 g LYZONE 2g 2g MEDICAROM GROUP S.R.L. MEDOCEF 2g 2g MEDOCHEMIE LTD.
CEFOZON 500 mg 500 mg E.I.P.I.CO. MED S.R.L. J01DD12 CEFOPERAZONUM PULB. PT. SOL. INJ./ 1 g PERF. I.M./I.V. CEFOZON 1 g 1 g E.I.P.I.CO. MED S.R.L. ________________________________________________________________________________ ______________________________________________________________________________ | 635 |J01DE02| CEFPIROMUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J01DE02 CEFPIROMUM PULB. PT. SOL. INJ./ 1 g PERF. CEFROM(R) 1 g 1 g LAB. AVENTIS J01DE02 CEFPIROMUM PULB. PT. SOL. INJ./ 2 g PERF.
CEFROM(R) 2 g 2 g LAB. AVENTIS ________________________________________________________________________________ ______________________________________________________________________________ | 636 |J01DH02| MEROPENEMUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J01DH02 MEROPENEMUM PULB. PT. SOL. INJ. 1 g I.V./PERF. MERONEM IV 1 g 1 g ASTRAZENECA UK LTD. J01DH02 MEROPENEMUM PULB. PT. SOL. INJ. 500 mg I.V./PERF. MERONEM IV 500 mg 500 mg ASTRAZENECA UK LTD. ________________________________________________________________________________ ______________________________________________________________________________ | 637 |J01DH51| IMIPENEMUM + CILASTATINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J01DH51 IMIPENEMUM + PULB. PT. SOL. PERF. CILASTATINUM TIENAM I.V. MERCK SHARP & DOHME ROMANIA S.R.L. ________________________________________________________________________________ ______________________________________________________________________________ | 638 |J01EE01| SULFAMETHOXAZOLUM + TRIMETHOPRIMUM | | |_______|_______|____________________________________________|_________________|
Yüklə 4,39 Mb. Dostları ilə paylaş:
|